Xcout Intel
Egle Therapeutics
Egle Therapeutics SAS is a clinical-stage biotechnology company headquartered in Paris, France, that develops precision medicines designed to modulate regulatory T cells.
The full profile of Egle Therapeutics
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Egle Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks Egle Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.